首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >Fibrosing Cholestatic Hepatitis: Clinicopathologic Spectrum Diagnosis and Pathogenesis
【2h】

Fibrosing Cholestatic Hepatitis: Clinicopathologic Spectrum Diagnosis and Pathogenesis

机译:纤维化胆汁淤积性肝炎:临床病理频谱诊断和发病机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fibrosing cholestatic hepatitis (FCH) is a rapidly progressive, sometimes fatal form of liver injury. Though originally reported in liver transplant recipients with recurrent hepatitis B, it has now been recognized frequently in chronic hepatitis B or C patients who are under immunosuppression. The histopathologic hallmarks in the liver include marked hepatocytic injury, severe cholestasis, and periportal and pericellular fibrosis. The pathogenesis is largely unknown. The aim of this review is to describe the spectrum of clinical conditions in which FCH occurs, common histopathologic findings, features unique to certain underlying diseases, factors to be considered in differential diagnosis, and our current understanding of pathogenesis of this disease.
机译:纤维化胆汁淤积性肝炎(FCH)是一种快速进行性,有时是致命性的肝损伤形式。尽管最初在患有复发性乙型肝炎的肝移植受者中报道,但现在已在免疫抑制的慢性乙型或丙型肝炎患者中被频繁识别。肝脏的组织病理学特征包括明显的肝细胞损伤,严重的胆汁淤积以及门静脉和细胞周围纤维化。发病机理很大程度上未知。这篇综述的目的是描述发生FCH的临床状况,常见的组织病理学发现,某些潜在疾病所独有的特征,鉴别诊断中要考虑的因素以及我们目前对该疾病的发病机理的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号